Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 9, 1999 - Issue 10
Submit an article Journal homepage
45
Views
5
CrossRef citations to date
0
Altmetric
Review

Benzodiazepine recognition site ligands and GABAA receptors

Ian L Martin Pharmaceutical Sciences Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK. [email protected]
&
Eric Lattmann Pharmaceutical Sciences Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK. [email protected]
Pages 1347-1358 | Published online: 25 Feb 2005

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

John R Atack. (2005) The benzodiazepine binding site of GABAA receptors as a target for the development of novel anxiolytics. Expert Opinion on Investigational Drugs 14:5, pages 601-618.
Read now

Articles from other publishers (4)

Shujuan Jin, Olivier St-Jean, Sandra I. Baltatu, Vijayaratnam Santhakumar & Mirosław J. Tomaszewski. (2012) Rapid access to pyrido[1,2,5]triazepin-4-ones through intramolecular nucleophilic aromatic substitution. Tetrahedron Letters 53:10, pages 1278-1281.
Crossref
Eric Lattmann, Harjit Singh, Pornthip Lattmann, Yodchai Boonprakob & Jintana Sattayasai. (2006) Synthesis and evaluation of N-(3-oxo-2,3-dihydro-1 H -pyrazol-4-yl)-1 H -indole-carboxamides as cholecystokinin antagonists . Journal of Pharmacy and Pharmacology 58:3, pages 393-401.
Crossref
Eric Lattmann, Jintana Sattayasai, David C Billington, David R Poyner, Prapawadee Puapairoj, Siriporn Tiamkao, Wanchai Airarat, Harjit Singh & Michael Offel. (2002) Synthesis and evaluation of N1-substituted-3-propyl-1,4-benzodiazepine-2-ones as cholecystokinin (CCK2) receptor ligands. Journal of Pharmacy and Pharmacology 54:6, pages 827-834.
Crossref
Donald J. AbrahamKevin S. Currie. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 525 597 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.